Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

iShares iBonds Dec 2027 Term Corporate ETF (IBDS)

23.77   0.02 (0.08%) 06-26 19:16
Open: 23.77 Pre. Close: 23.75
High: 23.85 Low: 23.73
Volume: 89,136 Market Cap: 0(M)
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index. The index is composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2027.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 23.88 - 23.97 23.97 - 24.06
Low: 23.48 - 23.6 23.6 - 23.71
Close: 23.59 - 23.76 23.76 - 23.93

Technical analysis

as of: 2022-06-24 4:40:42 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 28.12     One year: 28.68
Support: Support1: 23.3    Support2: 19.39
Resistance: Resistance1: 24.08    Resistance2: 24.55
Pivot: 23.75
Moving Average: MA(5): 23.68     MA(20): 23.89
MA(100): 24.65     MA(250): 25.92
MACD: MACD(12,26): -0.2     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 43.6     %D(3): 36.4
RSI: RSI(14): 43.6
52-week: High: 28.96  Low: 23.3
Average Vol(K): 3-Month: 186 (K)  10-Days: 125 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ IBDS ] has closed below upper band by 48.2%. Bollinger Bands are 50.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.

Headline News

Sat, 25 Jun 2022
Researchers Uncover Factors Associated With NAFLD in Patients With IBD - Gastroenterology & Endoscopy News

Thu, 23 Jun 2022
Does Poor Sleep Trigger IBD? - Gastroenterology & Endoscopy News

Fri, 17 Jun 2022
Understanding Cannabis as a Treatment for Ulcerative Colitis and IBD - Healthline

Thu, 09 Jun 2022
Celiac Disease and IBD Show Strong Bidirectional Link - Medscape

Wed, 08 Jun 2022
Despite Risk for Complications, Women With IBD Can Still Have a Healthy Pregnancy - Everyday Health

Wed, 08 Jun 2022
Understanding the Difference Between IBS and IBD - Orlando Health

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Shares Out. 0 (M)
Shares Float 0 (M)
% Held by Insiders 0 (%)
% Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.